Q1 2025 · 13F-HR/A
Exome Asset Management LLCholdings as filed
Filed 2025-05-16 · accession 0001420506-25-001316
$112.5M
Reported value
59
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $5.7M | 5.09% | 165,496 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $5.4M | 4.82% | 127,182 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $5.1M | 4.54% | 3,215,457 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $4.7M | 4.20% | 32,534 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $4.2M | 3.70% | 103,483 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $4.1M | 3.68% | 337,198 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $4.1M | 3.64% | 135,616 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $3.9M | 3.43% | 4,673 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $3.7M | 3.31% | 621,678 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $3.1M | 2.80% | 6,358 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.1M | 2.76% | 43,441 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $3.1M | 2.75% | 76,379 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $3.1M | 2.72% | 61,656 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $2.9M | 2.60% | 217,294 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $2.9M | 2.58% | 405,281 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $2.9M | 2.56% | 294,846 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.7M | 2.41% | 84,339 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $2.7M | 2.40% | 258,391 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $2.6M | 2.34% | 18,650 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $2.6M | 2.29% | 353,882 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $2.4M | 2.14% | 9,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $2.3M | 2.06% | 836,397 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $2.2M | 1.93% | 116,623 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $2.1M | 1.88% | 118,017 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.1M | 1.82% | 142,744 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $2.1M | 1.82% | 25,400 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $2.0M | 1.76% | 689,137 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.8M | 1.58% | 102,944 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $1.8M | 1.58% | 263,841 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $1.8M | 1.57% | 6,500 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $1.7M | 1.53% | 51,295 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $1.6M | 1.40% | 71,438 | Common | SOLE |
| 256135203 | RDY | DR REDDYS LABS LTD | $1.5M | 1.38% | 117,500 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $1.5M | 1.37% | 289,690 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $1.5M | 1.35% | 2,000,000 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.5M | 1.35% | 2,232,453 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $1.4M | 1.22% | 195,295 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.2M | 1.07% | 1,097,999 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $1.0M | 0.92% | 163,738 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $982,374 | 0.87% | 133,113 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $959,196 | 0.85% | 39,900 | Common | SOLE |
| L01800108 | ALVO | ALVOTECH | $871,267 | 0.77% | 90,100 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $731,225 | 0.65% | 462,801 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $534,546 | 0.48% | 13,100 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $454,500 | 0.40% | 60,600 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $386,952 | 0.34% | 114,145 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $363,047 | 0.32% | 189,087 | Common | SOLE |
| 89422G907 | — | TRAVERE THERAPEUTICS INC | $231,000 | 0.21% | 110,000 | CALL | SOLE |
| 01438T956 | — | ALDEYRA THERAPEUTICS INC | $190,000 | 0.17% | 100,000 | PUT | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $169,507 | 0.15% | 96,311 | Common | SOLE |
| 23282W955 | — | CYTOKINETICS INC | $141,450 | 0.13% | 23,000 | PUT | SOLE |
| 85205L907 | — | SPRINGWORKS THERAPEUTICS INC | $129,375 | 0.12% | 37,500 | CALL | SOLE |
| 76243J955 | — | RHYTHM PHARMACEUTICALS INC | $70,000 | 0.06% | 40,000 | PUT | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $59,103 | 0.05% | 28,972 | Common | SOLE |
| 38341P902 | — | GOSSAMER BIO INC | $47,500 | 0.04% | 100,000 | CALL | SOLE |
| 640268908 | — | NEKTAR THERAPEUTICS | $22,500 | 0.02% | 75,000 | CALL | SOLE |
| G76279951 | — | ROIVANT SCIENCES LTD | $15,060 | 0.01% | 75,300 | PUT | SOLE |
| 92536C903 | — | VERU INC | $900 | 0.00% | 60,000 | CALL | SOLE |
| 834203959 | — | SOLENO THERAPEUTICS INC | $275 | 0.00% | 11,000 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.